RecruitingPhase 3NCT06739122
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Sponsor: Eli Lilly and Company
Buffalo, NY · Hyde Park, NY · Syracuse, NY · +38 more sites
Type 2 Diabetes clinical trials in Syracuse, NY
4 recruiting type 2 diabetes studies with a site in Syracuse, NY.
RecruitingPhase not listedNCT06481904
Registry for Stage 2 Type 1 Diabetes
Sponsor: Sanofi
Buffalo, NY · Manhasset, NY · Staten Island, NY · +34 more sites
RecruitingNot applicableNCT07215533
Effects of HIIT vs. TRE on Type 2 Diabetes Risk
Sponsor: Syracuse University
Syracuse, NY
Not yet recruitingPhase 3NCT07668336
A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
Sponsor: Eli Lilly and Company
Syracuse, NY · The Bronx, NY · +15 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.